Hbk Investments L P Incyte Corp Transaction History

Hbk Investments L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$63.56 - $88.17 $138,052 - $191,505	-2,172 Reduced 9.93%	19,700 $1.69 Million
Q2 2018 Aug 14, 2018	SELL	$60.85 - $83.98 $3.22 Million - $4.45 Million	-52,967 Reduced 70.77%	21,872 $1.47 Million
Q4 2017 Feb 14, 2018	SELL	$93.56 - $116.6 $9.23 Million - $11.5 Million	-98,658 Reduced 56.86%	74,839 $7.09 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $18.9 Million - $24 Million	173,497	173,497 $20.3 Million

657

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.